TINNITUSFREETHE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
THE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
Tinnitus affects up to 15% of the global population—over 750 million people worldwide. For 20% of those affected (150 million people), the condition is severely debilitating, destroying sleep, concentration, careers, and mental health.
Despite affecting more people than diabetes or Alzheimer's, tinnitus research receives a fraction of the funding. There is currently no cure, largely because research remains critically underfunded.
The TinnitusFree Foundation tackles this funding gap by supporting innovative scientific research and connecting researchers, institutions, and funding partners.
Why tinnitus research remains critically underfunded
Traditional funders won't take the necessary risks. Private funding enables:
Research funding alone won't solve tinnitus—we must also prevent the next generation from developing it. The number of young people with tinnitus has doubled in recent years, primarily due to headphone use and noise exposure at concerts, festivals, and nightlife.
By raising public awareness about hearing protection, safe listening levels, and occupational risks, we can stop millions from developing tinnitus before it starts.
Simple behavioral changes today can spare the next generation from lifelong suffering.
Building the Evidence Base for Breakthrough Treatments
Traditional research methods have failed to produce any FDA or CE-approved treatments after decades of effort. We need a fundamentally different strategy.
Inspired by the "War On AIDS" research model, this initiative employs every relevant scientific approach simultaneously—funding more than 14 different research approaches in parallel over 3-5 years.
Developing Objective Biomarkers and Assessment Tools
Without objective measurement tools, progress has been severely limited. We're developing biomarkers for tinnitus presence and severity and enabling more precise clinical trials.
Understanding Tinnitus in the Music Industry
Chris Martin, Bono, Eric Clapton, Martin Garrix, Lars Ulrich, and Bob Dylan all have tinnitus. We studied prevalence among professional music creators and identified industry-specific risk factors and combined it with the international meta-analysis of 67 scientific studies involving a total of 28,311 musicians from 21 countries.
Status: Data collection phase | 2024–2026. For more information see the NEWS section.
Using Patient Data to Identify Patterns
By collecting and analyzing data from thousands of patients, we can identify subtypes, risk factors, and potential treatment pathways that smaller studies would miss.
The TinnitusFree Foundation collaborates with leading researchers and clinicians worldwide who are dedicated to advancing tinnitus science and treatment.
Your contribution supports carefully vetted, high-quality research projects with clear objectives and methodologies. We handle due diligence, project management, and impact reporting.
We pool resources with other funders to support larger-scale projects that achieve greater impact than individual grants alone.
We provide detailed reporting on how funds are used, research progress, and outcomes achieved.
Contact us at noise@tinnitusfree.eu
March, 2026
Chris Martin, Bono, Eric Clapton, Martin Garrix, Lars Ulrich, and Bob Dylan all have tinnitus. We studied prevalence among professional music creators and identified industry-specific risk factors and combined it with the international meta-analysis of 67 scientific studies involving a total of 28,311 musicians from 21 countries.
Read More →October 30, 2025
TinnitusFree has funded the purchase of a NeurOptics® NPi®-300 pupillometer for the University of Otago. This high-end pupillometer is a portable, automated measuring device that accurately and objectively measures pupil size, symmetry and response to light in patients. It provides measurable certainty and improves interprofessional reliability. The pupillometer will be used for the clinical trials of the Neuromodulator at the University of Otago, New Zealand, to measure the effect of neuromodulation. Pupil reduction indicates that the patient is relaxing. The Neuromodulator device is developed by the Technical University of Delft and the Brai3n Centre for Neuromodulation in Gent, under supervision of professor Wouter Serdijn (TU Delft) and Professor Dirk de Ridder (University of Otago).
July 9, 2025
The TinnitusFree Foundation has announced funding for a pioneering international research project aimed at identifying the world's first objective diagnostic marker for tinnitus—a major step toward transforming how this condition is diagnosed and treated.
Read More →The TinnitusFree Foundation is registered as a Public Benefit Organisation (ANBI) by the Dutch tax authorities under ID no. 859779890. Dutch Chamber of Commerce registration (KvK) no. 74122274.
TINNITUSFREETHE TINNITUSFREE FOUNDATION SUPPORTS WORLD-CLASS RESEARCHERS IN THE SEARCH FOR EFFECTIVE TINNITUS TREATMENTS.
Tinnitus affects up to 15% of the global population—over 750 million people worldwide. For 20% of those affected (150 million people), the condition is severely debilitating.
The TinnitusFree Foundation tackles this funding gap by supporting innovative scientific research and connecting researchers, institutions, and funding partners.
Why tinnitus research remains critically underfunded
The number of young people with tinnitus has doubled in recent years, primarily due to headphone use and noise exposure at concerts, festivals, and nightlife.
Funding more than 14 different research approaches in parallel over 3–5 years, inspired by the "War On AIDS" model.
Developing biomarkers for tinnitus presence and severity, enabling more precise clinical trials.
Studying tinnitus prevalence among professional music creators including Chris Martin, Bono, and Martin Garrix.
For more information see the NEWS section.
Using patient data from thousands of participants to identify subtypes and treatment pathways.
The TinnitusFree Foundation collaborates with leading researchers and clinicians worldwide who are dedicated to advancing tinnitus science and treatment.
Your contribution supports carefully vetted, high-quality research projects. We handle due diligence, project management, and impact reporting.
We pool resources with other funders to support larger-scale projects that achieve greater impact than individual grants alone.
Contact us at noise@tinnitusfree.eu
March, 2026
Chris Martin, Bono, Eric Clapton, Martin Garrix, Lars Ulrich, and Bob Dylan all have tinnitus. We studied prevalence among professional music creators and identified industry-specific risk factors and combined it with the international meta-analysis of 67 scientific studies involving a total of 28,311 musicians from 21 countries.
Read More →October 30, 2025
TinnitusFree has funded the purchase of a NeurOptics® NPi®-300 pupillometer for the University of Otago. This high-end pupillometer is a portable, automated measuring device that accurately and objectively measures pupil size, symmetry and response to light in patients. It provides measurable certainty and improves interprofessional reliability. The pupillometer will be used for the clinical trials of the Neuromodulator at the University of Otago, New Zealand, to measure the effect of neuromodulation. Pupil reduction indicates that the patient is relaxing. The Neuromodulator device is developed by the Technical University of Delft and the Brai3n Centre for Neuromodulation in Gent, under supervision of professor Wouter Serdijn (TU Delft) and Professor Dirk de Ridder (University of Otago).
July 9, 2025
The TinnitusFree Foundation has announced funding for a pioneering international research project aimed at identifying the world's first objective diagnostic marker for tinnitus—a major step toward transforming how this condition is diagnosed and treated.
Read More →Registered as ANBI by Dutch tax authorities, ID no. 859779890. KvK no. 74122274.